Resveratrol inhibits steroidogenesis in human fetal adrenocortical cells at the end of first trimester

Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus

(2016) R.H.X. Wong et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

The pharmacology of resveratrol in animals and humans

(2015) Eun-Jung Park et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

(2015) R. Scott Turner et al.   NEUROLOGY

Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men

(2015) Thomas Nordstrøm Kjaer et al.   PROSTATE

Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation

(2014) Chun-Ju Lin et al.   BIOCHEMICAL PHARMACOLOGY

Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates

(2014) Victoria H. J. Roberts et al.   FASEB JOURNAL

Inhibition of CYP17A1 activity by resveratrol, piceatannol, and synthetic resveratrol analogs

(2014) Agneta Oskarsson et al.   PROSTATE

Serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, Δ4-androstenedione and testosterone in children determined by TurboFlow-LC–MS/MS

(2013) T. Søeborg et al.   CLINICA CHIMICA ACTA

Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions

(2012) A. R. Neves et al.   CURRENT MEDICINAL CHEMISTRY

Backdoor pathway for dihydrotestosterone biosynthesis: Implications for normal and abnormal human sex development

(2012) Maki Fukami et al.   DEVELOPMENTAL DYNAMICS

Resveratrol metabolites have an antiproliferative effect on intestinal epithelial cancer cells

(2012) Carolina Emilia Storniolo et al.   FOOD CHEMISTRY

Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia

(2012) S.L. Bourque et al.   PLACENTA

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

(2011) Silvie Timmers et al.   Cell Metabolism

Effect of food on the pharmacokinetic profile of trans-resveratrol

(2011) M. Vaz-da-Silva et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Increased Activation of the Alternative “Backdoor” Pathway in Patients with 21-Hydroxylase Deficiency: Evidence from Urinary Steroid Hormone Analysis

(2011) Clemens Kamrath et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

(2010) V. A. Brown et al.   CANCER RESEARCH

Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients

(2010) K. R. Patel et al.   CANCER RESEARCH

Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects

(2010) Charles la Porte et al.   CLINICAL PHARMACOKINETICS

Effects of resveratrol analogs on steroidogenesis and mitochondrial function in rat Leydig cellsin vitro

(2009) Konstantin Svechnikov et al.   JOURNAL OF APPLIED TOXICOLOGY

Assessment of Circulating Sex Steroid Levels in Prepubertal and Pubertal Boys and Girls by a Novel Ultrasensitive Gas Chromatography-Tandem Mass Spectrometry Method

(2009) Frédérique Courant et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM